10
Loading video...

By Robert Kelly
Senior Vice President, Global Marketing & Operations, Merck Animal Health
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
Animal health is entering a new era of innovation. Veterinary medicines, vaccines, and technologies are advancing at a remarkable pace, resulting in breakthrough therapies and scientific discoveries across the industry.
The same breakthroughs transforming medicine for people—including mRNA technology, monoclonal antibodies, wearable devices, and AI-driven drug discovery—are rapidly reshaping the future of animal health and welfare. Innovations that once seemed out of reach are now readily available, benefiting farmers, pet owners, and society as a whole.
Despite these dramatic benefits, animal health accounts for just 0.6 percent of global health spending. That investment gap risks slowing one of the fastest-moving frontiers in medicine and delaying breakthroughs that benefit both animals and people. After all, animal health is not adjacent to human health but integral to it. As we explore new scientific frontiers, we are only beginning to see what's possible.
Read More on Opinion
We don't have to imagine why these breakthroughs matter. The latest example is already here.

...
New World screwworm—a parasitic fly that lays flesh-eating maggots in warm-blooded animals–has entered the United States, threatening farm animals, companion animals, and the nation's beef supply. Though previous outbreaks in Texas during the 1970s and the Florida Keys in 2016 were ultimately contained, the parasite's return has alarmed farmers and pet owners.
Thankfully, we have powerful new tools to suppress this outbreak and others like it. Scientists are using gene-editing techniques—originally developed to help treat human diseases—to produce sterile flies that could stop the parasite's rapid reproduction. Novel pour-on treatments to prevent and treat screwworm are being deployed in southern border states, prioritizing prevention as the first line of defense. The USDA is funding some 40 research projects on experimental approaches to kill off screwworm.
It's part of a much broader wave of innovation.
Consider RNA technology. Animal health scientists have been leveraging it for more than a decade, including through a distinct approach known as RNA particle technology, which utilizes self-amplifying RNA. Novel vaccines for swine influenza, canine influenza, and feline leukemia use this specialized technology to design and deliver mRNA sequences, helping to secure the food supply and keep our pets healthy.
Meanwhile, mRNA technology has dramatically accelerated vaccine development for both humans and animals. Researchers in Australia are looking into an mRNA vaccine for foot-and-mouth disease in cattle, further strengthening the fight against one of the world's most devastating livestock diseases. And in the United Kingdom, researchers are using mRNA technology to guard against the ongoing threat of avian influenza.
Similarly, monoclonal antibody therapies—which have transformed care for people with cancer, autoimmune diseases, and other conditions—are now being used to treat mast cell tumors and melanomas in dogs, reduce severe itching caused by atopic dermatitis, and relieve pain from osteoarthritis.
The same sorts of monitoring tools that help people track their steps, heart rate, sleep, and blood oxygen content have spread to animal health, too. Farmers now rely on smart monitoring collars and ear tags—technologies designed to detect behavioral changes that could identify potential diseases in cattle before they show symptoms.
These tools enable farmers and veterinarians to intervene early, before animals get seriously ill and require more expensive treatments or euthanasia. These technologies are increasingly moving beyond animal identification and monitoring to help livestock producers improve farm productivity and manage operations more efficiently.
As advanced therapies become more effective and data-driven tools provide real-time health insights, the industry is shifting toward a more proactive model of care, resulting in better outcomes for animals and the people who care for them.
That's significant for humans, too. Roughly 75 percent of emerging infectious diseases that afflict humans originate in animals. Healthier animals mean healthier people.
Animal health also underpins global food security, sustainability, and international stability. A recent report from the Organization for Economic Co-operation and Development found that eliminating global undernourishment would require a 15 percent increase in agricultural productivity.
Innovation doesn't just flow in one direction. Discoveries made by veterinary scientists often have potential applications in human medicine. Consider ivermectin, which was first developed for veterinary use before the human formulation became one of the world's most successful treatments for river blindness and lymphatic filariasis, improving millions of lives across the globe.
As the return of the New World screwworm shows, animal diseases aren't just concerns for farmers and veterinarians. Animal health progress is human health progress. It's time our investment reflected that reality.
Robert Kelly is senior vice president, global marketing and operations, Merck Animal Health.
The views expressed in this article are the writer’s own.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines